Lea Darrell Shane 4
4 · Cellectar Biosciences, Inc. · Filed Dec 12, 2023
Insider Transaction Report
Form 4
Lea Darrell Shane
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2023-06-23+100,000→ 100,000 totalExercise: $1.68Exp: 2033-01-17→ Common Stock (100,000 underlying) - Award
Common Stock
2023-12-08+39,599→ 39,599 total
Footnotes (2)
- [F1]This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day.
- [F2]This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023.